When given before a stem cell transplant, busulfan plus melphalan, improved progression-free survival in patients with myeloma, but came with some extra adverse events.
Lori Williams, PhD, APRN, AOCN, OCN
Advertisement
Articles by Lori Williams, PhD, APRN, AOCN, OCN
Advertisement
Latest Updated Articles
Balancing AEs With Improved Survival in MyelomaPublished: May 19th 2018 | Updated:
Advertisement
Advertisement
